Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Genomtec S.A.
4VICurrent price
1.71 EUR
+0.024 EUR (+1.43%)
Last closed
8 PLN
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Medical Devices
Exchange
Frankfurt Exchange
Capitalization
100 882 510 PLN
Yield for 12 month
-21.24 %
1Y
3Y
5Y
10Y
15Y
4VI
Genomtec S.A. researches, develops, manufactures, and commercializes innovative molecular diagnostic products in optical systems and isothermal nucleic acid amplification methods in Poland and internationally. The company develops Genomtec ID, a technological device that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analyzing the biological material of patients using swabs, urine samples, saliva, blood, and other body fluids. It also develops Genomtec Tumor, a SNAAT based solution used to identify neoplastic mutations and mutations with prognostic value in neoplastic disease; Genomtec SARS-CoV-2 EvaGreen and Direct-RT-LAMP CE-IVD Kit to detect SARS-CoV-2 RNA in various biological samples from patients with suspected COVID-19 infection; and Genomtec RT-LAMP CE-IVD Duo-Kit for the detection of all variants of the SARS-CoV-2 virus. Genomtec S.A was founded in 2016 and is based in Wroclaw, Poland. Address: Bierutowska Street 57-59, Wroclaw, Poland, 51-317
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
+1 001 PLN
Last Year
+39 999 PLN
Current Quarter
+266 002 PLN
Last Quarter
–
Current Year
-793 001 PLN
Last Year
-3 231 002 PLN
Current Quarter
-190 998 PLN
Last Quarter
-718 999 PLN
Key Figures 4VI
1 year
3 years
5 years
10 years
EBITDA
-7 683 001 PLN
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-41.61 %
PEG Ratio
–
Return On Equity TTM
-226.95 %
Wall Street Target Price
–
Revenue TTM
-89 000 PLN
Book Value
0.46 PLN
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100 %
Dividend Yield
–
Gross Profit TTM
9 000 PLN
Earnings per share
-0.79 PLN
Diluted Eps TTM
-0.79 PLN
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 4VI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4VI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 4VI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
755.6095
Price Sales TTM
8381.013
Enterprise Value EBITDA
-12.7568
Price Book MRQ
17.8743
Financials 4VI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4VI
For 52 weeks
7.8 PLN
14.4 PLN
50 Day MA
9.69 PLN
Shares Short Prior Month
–
200 Day MA
10.78 PLN
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart